Your session is about to expire
← Back to Search
Math-Enriching Texts for Early Math Skills Development (MATH Trial)
N/A
Recruiting
Led By Lisa Chamberlain, MD, MPH
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and month 9
Awards & highlights
No Placebo-Only Group
Summary
This trial examines if sending text messages with math activities to parents can improve early math skills in preschool-aged children in rural Oregon.
Who is the study for?
This trial is for parents of 3 or 4-year-old children who are eligible for Medicaid, receive care at an ORPRN clinic in rural Oregon, and can communicate in English or Spanish. Parents must be over 18 and able to consent.
What is being tested?
The study tests if text messages with early math tips sent to parents by pediatricians can improve the math skills of preschool-aged children. It compares kids getting these texts versus those receiving standard care.
What are the potential side effects?
Since this intervention involves sending educational text messages, there are no direct medical side effects. However, it's important to consider data privacy concerns related to receiving texts.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and month 9
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and month 9
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in child early math skills measured by the Research-based Early Math Assessment (REMA-Brief)
Secondary study objectives
Change in child literacy measured by the Phonological Awareness Literacy Screening Tools (PALS-PreK) Score
Change in parent confidence teaching math and literacy by the Development and Research in Early Math Education (DREME)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Children and parents receiving Early Math Texts (TipsbyText)
Group II: ControlActive Control1 Intervention
Children and parents not receiving Early Math Texts (TipsbyText)
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for early math learning, such as educational enrichment strategies, involve providing parents with resources and activities to integrate math learning into daily routines. These methods help children develop foundational skills like number recognition, counting, and basic arithmetic through engaging and interactive activities.
Emphasizing early math learning is important because it prepares children for future academic success and cognitive development, ensuring they are ready for more complex mathematical concepts as they advance in their education.
Teaching With Televised Stories: A Story-Focused Narrative Preview Supports Learning in Young Children.Targeting Complex Sentences in Older School Children With Specific Language Impairment: Results From an Early-Phase Treatment Study.Effects of a brief but intensive remedial computer intervention in a sub-sample of kindergartners with early literacy delays.
Teaching With Televised Stories: A Story-Focused Narrative Preview Supports Learning in Young Children.Targeting Complex Sentences in Older School Children With Specific Language Impairment: Results From an Early-Phase Treatment Study.Effects of a brief but intensive remedial computer intervention in a sub-sample of kindergartners with early literacy delays.
Find a Location
Who is running the clinical trial?
Oregon Health and Science UniversityLead Sponsor
1,006 Previous Clinical Trials
7,412,972 Total Patients Enrolled
Stanford UniversityOTHER
2,472 Previous Clinical Trials
17,500,818 Total Patients Enrolled
Lisa Chamberlain, MD, MPHPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child is participating, and I am at least 18 years old.My child and I can communicate in English or Spanish.My child is too sick to take part in the study.My child has a developmental delay or a condition like autism, but not just speech delay.I am a parent unable to participate in study activities.My child is either 3 or 4 years old.I am a parent and can give informed consent.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger